Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 09-2002 | 09-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,802 | N/A | N/A | -500,790 | -296,480 |
| Depreciation Amortization | 37 | N/A | N/A | 76,510 | 102,840 |
| Accounts payable and accrued liabilities | 887 | N/A | N/A | N/A | N/A |
| Other Working Capital | 7,549 | N/A | N/A | -21,750 | -20,400 |
| Other Operating Activity | 386 | 0 | 0 | 329,110 | 137,190 |
| Operating Cash Flow | $-14,944 | $N/A | $N/A | $-116,920 | $-76,850 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -427 | N/A | N/A | -15,980 | -31,590 |
| Net Acquisitions | N/A | N/A | N/A | -118,870 | -23,500 |
| Other Investing Activity | 0 | 0 | 0 | 166,890 | 105,690 |
| Investing Cash Flow | $-427 | $N/A | $N/A | $32,040 | $50,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,436 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 83,650 | 3,610 |
| Financing Cash Flow | $11,436 | $N/A | $N/A | $83,650 | $3,610 |
| Exchange Rate Effect | -122 | N/A | N/A | -3 | -720 |
| Beginning Cash Position | 4,356 | N/A | N/A | 18,510 | 41,870 |
| End Cash Position | 299 | N/A | N/A | 17,290 | 18,510 |
| Net Cash Flow | $-4,057 | $N/A | $N/A | $-1,220 | $-23,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,944 | N/A | N/A | -116,920 | -76,850 |
| Capital Expenditure | -427 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -15,371 | 0 | 0 | -116,920 | -76,850 |